Cooperation of bisphosphonates with tyrosine kinase inhibitors in advanced non-small cell lung cancer with EGFR activation mutation: A retrospective study.
第一作者机构：[1]Sichuan Univ, West China Hosp, Ctr Canc, Dept Thorac Oncol, Chengdu 610064, Peoples R China[2]Sichuan Canc Hosp, Dept Lung Canc Med Oncol, Chengdu, Peoples R China
推荐引用方式(GB/T 7714)：
Huang Chu-ying,Wang Li,Fang Cheng-jun,et al.Cooperation of bisphosphonates with tyrosine kinase inhibitors in advanced non-small cell lung cancer with EGFR activation mutation: A retrospective study.[J].JOURNAL OF CLINICAL ONCOLOGY.2014,32(15):doi:10.1200/jco.2014.32.15_suppl.e19073.
APA：
Huang, Chu-ying,Wang, Li,Fang, Cheng-jun,Yu, Ping&Wang, Yongsheng.(2014).Cooperation of bisphosphonates with tyrosine kinase inhibitors in advanced non-small cell lung cancer with EGFR activation mutation: A retrospective study..JOURNAL OF CLINICAL ONCOLOGY,32,(15)
MLA：
Huang, Chu-ying,et al."Cooperation of bisphosphonates with tyrosine kinase inhibitors in advanced non-small cell lung cancer with EGFR activation mutation: A retrospective study.".JOURNAL OF CLINICAL ONCOLOGY 32..15(2014)
医学